CN102070554B - 一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 - Google Patents
一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN102070554B CN102070554B CN201110022607A CN201110022607A CN102070554B CN 102070554 B CN102070554 B CN 102070554B CN 201110022607 A CN201110022607 A CN 201110022607A CN 201110022607 A CN201110022607 A CN 201110022607A CN 102070554 B CN102070554 B CN 102070554B
- Authority
- CN
- China
- Prior art keywords
- methyl
- thiazolyl
- phenyl
- nitro
- carbonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 title claims abstract description 37
- -1 phenyl carbonic ether Chemical compound 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- 238000001953 recrystallisation Methods 0.000 claims abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 35
- QIIPQYDSKRYMFG-UHFFFAOYSA-N phenyl hydrogen carbonate Chemical compound OC(=O)OC1=CC=CC=C1 QIIPQYDSKRYMFG-UHFFFAOYSA-N 0.000 claims description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- WKBQQWDVVHGWDB-UHFFFAOYSA-N 1,3-thiazol-5-ylmethanol Chemical compound OCC1=CN=CS1 WKBQQWDVVHGWDB-UHFFFAOYSA-N 0.000 claims description 11
- 150000002148 esters Chemical class 0.000 claims description 10
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 7
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003054 catalyst Substances 0.000 abstract description 2
- 238000009833 condensation Methods 0.000 abstract description 2
- 230000005494 condensation Effects 0.000 abstract description 2
- 239000012043 crude product Substances 0.000 abstract 2
- 239000000047 product Substances 0.000 abstract 2
- UMTUZYPMHPCDAK-UHFFFAOYSA-N carbonochloridic acid (2-nitrophenyl)-phenylmethanone Chemical compound ClC(=O)O.[N+](=O)([O-])C1=C(C(=O)C2=CC=CC=C2)C=CC=C1 UMTUZYPMHPCDAK-UHFFFAOYSA-N 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 7
- 238000001291 vacuum drying Methods 0.000 description 7
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 238000010792 warming Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 3
- 229960000311 ritonavir Drugs 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110022607A CN102070554B (zh) | 2011-01-20 | 2011-01-20 | 一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110022607A CN102070554B (zh) | 2011-01-20 | 2011-01-20 | 一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102070554A CN102070554A (zh) | 2011-05-25 |
CN102070554B true CN102070554B (zh) | 2012-10-10 |
Family
ID=44029335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110022607A Active CN102070554B (zh) | 2011-01-20 | 2011-01-20 | 一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102070554B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115541762B (zh) * | 2022-10-11 | 2024-08-09 | 武汉海特生物创新医药研究有限公司 | 一种利托那韦起始物料02有关物质的检测方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773625A (en) * | 1997-10-02 | 1998-06-30 | Abbott Laboratories | Process for the preparation of disubstituted carbonates |
CN101362735B (zh) * | 2008-09-16 | 2011-01-05 | 山东金城医药化工股份有限公司 | 2-[[(苯甲氧基)羰基]氨基]-4-噻唑基乙酸酯的制备方法 |
-
2011
- 2011-01-20 CN CN201110022607A patent/CN102070554B/zh active Active
Non-Patent Citations (1)
Title |
---|
石滨.抗艾滋病药物-利托那韦中间体的合成研究.《中国优秀硕士学位论文全文数据库 医药卫生科技辑》.2009,(第04期),第3章,第四章. * |
Also Published As
Publication number | Publication date |
---|---|
CN102070554A (zh) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106810426B (zh) | 一种大麻二酚的合成方法 | |
CN102060815B (zh) | 一种紫杉烷类化合物的制备方法 | |
CN111961018B (zh) | 一种高纯度丁苯酞的制备方法 | |
CN109836401B (zh) | 一种多西他赛的纯化方法 | |
CN101208312A (zh) | 用于合成阿那曲唑及纯化一种阿那曲唑中间体的方法 | |
CN104387393A (zh) | 制备西格列汀杂质 | |
CN102070554B (zh) | 一种(5-噻唑基)甲基-(4’-硝基)苯基碳酸酯盐酸盐的制备方法 | |
CN106146334B (zh) | 2,3-二芳基-2-炔丙酰胺基-3-芳基氨基丙酸甲酯衍生物及其制备方法和应用 | |
CN103601777A (zh) | 一种卡培他滨的制备方法 | |
CN104557576B (zh) | 一种高纯度普瑞巴林的制备方法 | |
CN104974105B (zh) | 一种制备4‑(4‑氨基苯基)‑3‑吗啉酮的方法 | |
WO2013008194A2 (en) | Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof | |
CN109988127B (zh) | 由7差向-10-去乙酰基紫杉醇合成紫杉醇的方法 | |
KR101806782B1 (ko) | 고순도 바제독시펜 아세테이트의 제조방법 | |
WO2014188445A1 (en) | PROCESS FOR THE PREPARATION OF (3β)-17-(3-PYRIDINYL)ANDROSTA-5,16-DIEN-3-YL ACETATE AND POLYMORPH THEREOF | |
CN101381356B (zh) | 辛伐他汀的制备方法 | |
AU2008209271A1 (en) | A novel crystalline mycophenolate sodium polymorph and processes to manufacture same | |
CN110950770B (zh) | 一种拉考沙胺的合成方法 | |
CN113816914A (zh) | 一种劳拉西泮中间体的制备方法 | |
CN102432616B (zh) | 一种制备l-脯氨酰胺及其中间体的方法 | |
CN111377822B (zh) | 一种维兰特罗的制备方法 | |
CN103183592B (zh) | 2-氯-1,1,1-三烷氧基乙烷的制备方法 | |
CN114853666A (zh) | 一种制备高纯度吡仑帕奈中间体的纯化方法 | |
CN105273030A (zh) | 一种高纯度的二氟泼尼酯的制备方法 | |
CN105153167A (zh) | 一种替格瑞洛结晶及含有该结晶的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN WEIJIE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TIANJIN WEIJIEKAIHUA TECHNOLOGY CO., LTD. Effective date: 20141105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300192 NANKAI, TIANJIN TO: 300480 HANGU, TIANJIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141105 Address after: 300480 No. 28, Qixia Road, Hangu modern industrial district, Tianjin economic and Technological Development Zone Patentee after: Tianjin Weijie Pharmaceutical Co., Ltd. Address before: 300192, No. 3, building 2, Biomedical Engineering Research Institute, No. 236 Bai Causeway Road, Tianjin, Nankai District Patentee before: Tianjin Weijiekaihua Technology Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Process for preparing (5- thiazole) methyl - (4 '- Nitro) phenyl carbonate hydrochloride Effective date of registration: 20160315 Granted publication date: 20121010 Pledgee: Ni Wenshuo Pledgor: Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2016120000006 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200526 Granted publication date: 20121010 Pledgee: Ni Wenshuo Pledgor: TIANJIN WEIJIE PHARMACEUTICAL Co.,Ltd. Registration number: 2016120000006 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of (5-thiazolyl) methyl - (4 '- Nitro) phenyl carbonate hydrochloride Effective date of registration: 20200526 Granted publication date: 20121010 Pledgee: Zhongxinxing financial (Beijing) Investment Fund Management Co., Ltd Pledgor: TIANJIN WEIJIE PHARMACEUTICAL Co.,Ltd. Registration number: Y2020990000523 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |